HealthEquity Announces Record Year-End HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference
HealthEquity (NASDAQ: HQY), the largest HSA custodian in the US, announced strong fiscal year-end estimates for January 31, 2025. The company projects approximately 9.8 million HSAs, up from 8.7 million the previous year, and HSA Assets of approximately $31 billion, increasing from $25.2 billion, including $17 billion in HSA Cash.
Total Accounts are estimated to reach 17 million, compared to 15.7 million at the end of fiscal year 2024. The company achieved nearly 1 million New HSAs from Sales and maintains an integrated network of over 200 Network Partners. Management will present these results at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025.
HealthEquity (NASDAQ: HQY), il più grande custode di HSA negli Stati Uniti, ha annunciato stime solide di fine anno fiscale per il 31 gennaio 2025. L'azienda prevede circa 9,8 milioni di HSA, in aumento rispetto agli 8,7 milioni dell'anno precedente, e Attività HSA di circa 31 miliardi di dollari, in aumento da 25,2 miliardi, di cui 17 miliardi in contante HSA.
Si stima che il numero totale di conti raggiunga 17 milioni, rispetto ai 15,7 milioni alla fine dell'anno fiscale 2024. L'azienda ha ottenuto quasi 1 milione di nuove HSA dalle vendite e mantiene una rete integrata di oltre 200 partner di rete. La direzione presenterà questi risultati alla 43esima Conferenza Annuale sulla Salute J.P. Morgan il 15 gennaio 2025.
HealthEquity (NASDAQ: HQY), el mayor custodio de HSA en los EE. UU., anunció estimaciones sólidas de fin de año fiscal para el 31 de enero de 2025. La empresa proyecta aproximadamente 9,8 millones de HSA, un aumento con respecto a los 8,7 millones del año anterior, y Activos HSA de aproximadamente 31 mil millones de dólares, en incremento desde 25,2 mil millones, incluyendo 17 mil millones en efectivo HSA.
Se estima que el total de cuentas alcance 17 millones, en comparación con los 15,7 millones a finales del año fiscal 2024. La empresa logró cerca de 1 millón de nuevas HSA a través de ventas y mantiene una red integrada de más de 200 socios de red. La dirección presentará estos resultados en la 43ª Conferencia Anual de Atención Médica J.P. Morgan el 15 de enero de 2025.
HealthEquity (NASDAQ: HQY), 미국에서 가장 큰 HSA 수탁 기관이 2025년 1월 31일 기준 회계연도 종료에 대한 강력한 추정치를 발표했습니다. 회사는 약 980만 개의 HSA를 예상하며, 이는 전년도 870만 개에서 증가한 수치입니다. HSA 자산은 약 310억 달러로, 252억 달러에서 증가하며, 이 중 170억 달러는 HSA 현금입니다.
총 계좌 수는 1700만 개에 이를 것으로 예상되며, 이는 2024 회계연도 종료 시점에 1570만 개와 비교됩니다. 회사는 판매를 통해 거의 100만 개의 신규 HSA를 달성했으며, 200개 이상의 네트워크 파트너와 통합 네트워크를 유지하고 있습니다. 경영진은 2025년 1월 15일에 열리는 제43회 J.P. Morgan 건강 관리 컨퍼런스에서 이러한 결과를 발표할 예정입니다.
HealthEquity (NASDAQ: HQY), le plus grand dépositaire de HSA aux États-Unis, a annoncé des estimations solides pour la fin de l'exercice qui se termine le 31 janvier 2025. L'entreprise prévoit environ 9,8 millions de HSA, en hausse par rapport à 8,7 millions l'année précédente, et des actifs HSA d'environ 31 milliards de dollars, contre 25,2 milliards de dollars, y compris 17 milliards de dollars en espèces HSA.
Le nombre total de comptes devrait atteindre 17 millions, contre 15,7 millions à la fin de l'exercice 2024. L'entreprise a généré près d'un million de nouvelles HSA grâce aux ventes et maintient un réseau intégré de plus de 200 partenaires. La direction présentera ces résultats lors de la 43e conférence annuelle sur la santé de J.P. Morgan le 15 janvier 2025.
HealthEquity (NASDAQ: HQY), der größte HSA-Verwalter in den USA, hat starke Schätzungen zum Geschäftsjahresende zum 31. Januar 2025 veröffentlicht. Das Unternehmen prognostiziert etwa 9,8 Millionen HSAs, ein Anstieg von 8,7 Millionen im Vorjahr, sowie HSA-Vermögenswerte von etwa 31 Milliarden Dollar, steigend von 25,2 Milliarden Dollar, einschließlich 17 Milliarden Dollar in HSA-Bargeld.
Die Gesamtanzahl der Konten wird auf 17 Millionen geschätzt, verglichen mit 15,7 Millionen am Ende des Geschäftsjahres 2024. Das Unternehmen erzielte fast 1 Million neue HSAs aus Verkäufen und hält ein integriertes Netzwerk von über 200 Netzwerkpartnern aufrecht. Das Management wird diese Ergebnisse auf der 43. jährlichen J.P. Morgan Gesundheitskonferenz am 15. Januar 2025 präsentieren.
- HSA accounts increased by 1.1 million to 9.8 million
- HSA Assets grew by $5.8 billion to $31 billion
- Total Accounts increased by 1.3 million to 17 million
- Added nearly 1 million New HSAs from Sales
- None.
Insights
The preliminary fiscal year-end results reveal impressive growth metrics across key performance indicators. The projected
The addition of nearly 1 million New HSAs from Sales demonstrates strong market penetration and effective partnership strategies through their network of over 200 partners. The Total Accounts projection of 17 million, up from 15.7 million, indicates a
This growth trajectory positions HealthEquity favorably in the expanding HSA market, particularly as healthcare costs continue to rise and tax-advantaged savings vehicles become increasingly attractive. The high proportion of assets in cash (
HealthEquity's market leadership position is strengthening with these results, particularly noteworthy given the competitive HSA custodian landscape. The robust growth in both accounts and assets suggests successful execution of their distribution strategy through health plans, employers and benefit advisors.
The increase in HSA Assets outpacing account growth indicates higher average balance per account, reflecting successful customer engagement and growing adoption of HSAs as long-term savings vehicles. This trend typically leads to higher customer retention and more stable revenue streams. The company's integrated network approach with over 200 partners creates significant barriers to entry for competitors while enabling efficient customer acquisition channels.
DRAPER, Utah, Jan. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced estimates of HSAs, HSA Assets and Total Accounts for its fiscal year ending January 31, 2025, reflecting a strong sales year with record New HSAs from Sales and strong custodial HSA Asset growth.
- Estimated HSAs to be approximately 9.8 million by January 31, 2025, up from 8.7 million a year earlier.
- Estimated HSA Assets to be approximately
$31 billion , up from$25.2 billion at the end of fiscal year 2024, with approximately$17 billion of HSA Cash. Invested balances included in the estimated assets are subject to market fluctuation. - Estimated Total Accounts to be approximately 17 million compared to 15.7 million at the end of fiscal year 2024.
Commenting on the estimates, Scott Cutler, President and CEO said, “I am excited to be part of Team Purple, who together with an integrated network of over 200 Network Partners that include health and retirement plan partners, brokers and benefit advisors, delivered strong new logo growth and, nearly 1 million New HSAs from Sales. Combined with strong HSA Asset growth, and Total Account growth, we are well positioned for continued growth in FY26 and beyond.”
HealthEquity will discuss these results and estimates during a presentation by Scott Cutler, President and CEO, Steve Neeleman, Vice Chair and Founder and James Lucania, EVP and CFO, at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 8:15 am Pacific Time in the Elizabethan Room of the St. Francis Hotel.
An audio webcast of the presentation along with a copy of the presentation slides will be available and archived on HealthEquity’s investor relations website at http://ir.healthequity.com.
About HealthEquity
HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for more than 16 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our vision of saving and improving the lives of healthcare consumers. For more information, visit www.healthequity.com.
Forward-looking statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our New HSAs from Sales, HSA Assets, Total Accounts, industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “aims,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.
Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following:
- our ability to adequately place and safeguard our custodial assets, or the failure of any of our depository or insurance company partners;
- our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry;
- our dependence on the continued availability and benefits of tax-advantaged HSAs and other CDBs;
- risks relating to our recent CEO transition;
- our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;
- the significant competition we face and may face in the future, including from those with greater resources than us;
- our reliance on the availability and performance of our technology and communications systems;
- potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business;
- the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;
- our ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser and other laws applicable to our business;
- our reliance on partners and third-party vendors for distribution and important services;
- our ability to develop and implement updated features for our technology platforms and communications systems; and
- our reliance on our management team and key team members.
For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the fiscal year ended January 31, 2024, our Quarterly Reports on Form 10-Q for the fiscal quarters ended July 31, 2024 and October 31, 2024, and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.
Investor Relations Contact:
Richard Putnam
801-727-1000
rputnam@healthequity.com
FAQ
What is HealthEquity's (HQY) projected HSA count for fiscal year 2025?
How much are HealthEquity's (HQY) estimated HSA assets for fiscal year 2025?
What is the total account growth for HealthEquity (HQY) in fiscal year 2025?
How many new HSAs did HealthEquity (HQY) add from sales in fiscal year 2025?
When will HealthEquity (HQY) present at the J.P. Morgan Healthcare Conference?
